Selected article for: "antibody detection and rapid detection"
Author: Martínez‐Girón, Rafael; Pantanowitz, Liron
Title: Lower respiratory tract viral infections: Diagnostic role of exfoliative cytology
  • Cord-id: v4mubff6
  • Document date: 2017_3_1
    • ID: v4mubff6
    Snippet: Viral lower respiratory tract infections (VLRTI) remain one of the most common causes of morbidity and mortality worldwide. For many years, the diagnosis of VLRTI was based on laboratory techniques such as viral isolation in cell culture, antigen detection by direct fluorescent antibody staining, and rapid enzyme immunoassay. Radiological imaging and morphology also play an important role in diagnosing these infections. Exfoliative cytology provides a simple, rapid, inexpensive, and valuable mea
    Document: Viral lower respiratory tract infections (VLRTI) remain one of the most common causes of morbidity and mortality worldwide. For many years, the diagnosis of VLRTI was based on laboratory techniques such as viral isolation in cell culture, antigen detection by direct fluorescent antibody staining, and rapid enzyme immunoassay. Radiological imaging and morphology also play an important role in diagnosing these infections. Exfoliative cytology provides a simple, rapid, inexpensive, and valuable means to diagnose and manage VLRTI. Here we review viral‐associated cytomorphological changes seen in exfoliated cells of the lower respiratory tract. Diagn. Cytopathol. 2017;45:614–620. © 2017 Wiley Periodicals, Inc.

    Search related documents:
    Co phrase search for related documents
    • acute sars cov respiratory syndrome coronavirus and adenovirus infection: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and low negative: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute sars cov respiratory syndrome coronavirus and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • acute sars cov respiratory syndrome coronavirus and low respiratory tract: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lung biopsy: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
    • acute sars cov respiratory syndrome coronavirus and lung parenchyma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute sars cov respiratory syndrome coronavirus and lung parenchymal involvement: 1
    • acute sars cov respiratory syndrome coronavirus and lung periphery: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and lymphocytic infiltrate: 1, 2
    • acute sars cov respiratory syndrome coronavirus and maculopapular rash: 1, 2, 3, 4, 5, 6, 7
    • additional study and low negative: 1
    • additional study and lung function: 1
    • additional study and lung parenchyma: 1
    • low respiratory and lung biopsy: 1
    • low respiratory and lung function: 1, 2, 3
    • low respiratory and lung parenchyma: 1, 2
    • low respiratory and lung parenchymal involvement: 1